Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

IL27 Antikörper (FITC)

Dieser Maus Monoklonal Antikörper erkennt spezifisch IL27 in FACS. Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN1107838

Kurzübersicht für IL27 Antikörper (FITC) (ABIN1107838)

Target

Alle IL27 Antikörper anzeigen
IL27 (Interleukin-27 Subunit alpha (IL27))

Reaktivität

  • 16
  • 14
  • 12
Human

Wirt

  • 18
  • 3
Maus

Klonalität

  • 18
  • 3
Monoklonal

Konjugat

  • 13
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser IL27 Antikörper ist konjugiert mit FITC

Applikation

  • 10
  • 5
  • 4
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
Flow Cytometry (FACS)

Klon

B-G49
  • Spezifität

    Recognizes both natural and recombinant Human IL-27

    Kreuzreaktivität (Details)

    Species reactivity (tested):Human.

    Aufreinigung

    Ion Exchange Chromatography.

    Immunogen

    Recombinant Human IL-27.

    Isotyp

    IgG2a
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    PBS with 5 % BSA as stabilizer and 0.09 % Sodium Azide as preservative.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C

    Informationen zur Lagerung

    Store the antibody undiluted at 2-8 °C.
  • Target

    IL27 (Interleukin-27 Subunit alpha (IL27))

    Andere Bezeichnung

    Interleukin-27 / IL27A

    Hintergrund

    Like interleukin-23 (IL-23), IL-27 is a recently discovered member of the IL-6/IL-12 family of proinflammatory and immunoregulatory cytokines. It exists as a heterodimer composed of the p40-related protein EBI3 and an IL-12 p35-related protein termed p28. IL-27 is produced after activation by antigen-presenting cells and induces proliferation of naive but not memory CD4+ T-cells. It acts by binding to its receptor WSX-1 and gp130 which results in the activation of a Jak/STAT signaling cascade, suggesting the IL-27 is involved in the regulation of immune processes. It has been suggested that IL-27 can also be used as a therapeutic agent against cancer as it can also induce tumor-specific anti-tumor activity mediated through CD8+ T-cells, IFN-gamma, and T-bet.Synonyms: IL-27 subunit alpha, IL-30, IL27-A, IL30, Interleukin-30, p28

    Gen-ID

    246778

    NCBI Accession

    NP_663634

    UniProt

    Q8NEV9
Sie sind hier:
Chat with us!